Join to View Full Profile
505 Parnassus AveSan Francisco, CA 94143
Phone+1 415-353-2350
Fax+1 415-353-2765
Dr. Quandt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am board certified in Internal Medicine and Endocrinology. My practice combines clinical care and research with a focus on patients who develop endocrine side effects from cancer therapies.
Education & Training
University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 2016 - 2019
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2013 - 2016- University of California San Francisco School of MedicineClass of 2013, MD
Certifications & Licensure
CA State Medical License 2014 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- Checkpoint Inhibitor-Induced Autoimmune Diabetes: An Autoinflammatory Disease.Zoe Quandt, Ana Perdigoto, Mark S Anderson, Kevan C Herold
Cold Spring Harbor Perspectives in Medicine. 2025-04-01 - Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.Pooja Middha, Rohit Thummalapalli, Zoe Quandt, Karmugi Balaratnam, Eduardo Cardenas
Journal for Immunotherapy of Cancer. 2025-03-28 - Polyfunctional IL-21IFNGT follicular helper cells contribute to checkpoint inhibitor diabetes mellitus and can be targeted by JAK inhibitor therapy.Nicole Huang, Jessica Ortega, Kyleigh Kimbrell, Joah Lee, Lauren N Scott
Biorxiv. 2024-12-03
Journal Articles
- Collateral Damage: Insulin-Dependent Diabetes Induced with Checkpoint InhibitorsRobert Rushakoff, Zoe Quandt, James Lee, Kevan C Herold, Diabetes Care
Press Mentions
Duping Antibodies with a Decoy, Researchers Aim to Prevent Rejection of Transplanted CellsJanuary 2nd, 2023
A Lifesaver with a Catch: Powerful New Cancer Drugs Can Trigger Diabetes--and No One Is Certain WhyJune 3rd, 2019
A Lifesaver with a Catch: Powerful New Cancer Drugs Can Trigger Diabetes — and No One Is Certain WhyMay 29th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
